Journal of the Chemical Society, Dalton Transactions p. 3379 - 3385 (1996)
Update date:2022-08-04
Topics:
Carfagna, Carla
Green, Michael
Mahon, Mary F.
McInnes, Jacqueline M.
Rumble, Simon J.
Woolhouse, Christopher M.
Reaction of the σ,η2(3e)-prop-2-ynyl/r|2(4e)-alkyne complex [Mo{σ,η2(3e)-CH2C2Me}{η 2(4e)-MeC2Me}-(η-C5H5)] with hexafluorobut-2-yne led to a novel cyclisation reaction affording an X-ray crystallographically identified complex containing an (η-C5H5)Mo fragment η3,η4 bonded to a bicyclo[4.3.0]nonyl ring system formed by the cocyclisation of two molecules of CF3C2CF3, a but-2-yne molecule and a prop-2-ynyl fragment. A mechanism of formation is proposed involving, in the final step, the placement of a hydrogen substituent on the opposite face of the bicyclo-ring system to which the molybdenum is attached, via the ionisation of an acidic Mo-H bond. The reactions of [Mo{σ,η2(3e)-CH2C2R}{η 2(4e)-MeC2R}(η-C5H5)] (R = Me or Ph) with carbon monoxide led to novel cocyclisation reactions and the formation of the X-ray crystallographically identified complexes [Mo{η2,η3-C(R)C(O)C(Me)C(R)CCH 2}(CO)(η-C5H5)]. Protonation (HBF4·Et2O) of the methyl-substituted system was shown by X-ray crystallography to involve protonation of the keto-group, rather than the η3-allylic CH2 group, to give the cationic complex [Mo{η3,η3-C(Me)C(OH)C(Me)C(Me)CCH 2}-(CO)(η-C5H5)][BF4].
Chengdu Green Young Biopharmaceutical INC
Contact:+86-28-85337952
Address:1-B-26,Tianhe Industry Park, No.1480 of Tianfu Road,Chengdu,P.R.China,610000
Xinchang Jiu Xin Pharmaceutical Co., Ltd
website:http://www.jiuxinpharm.com
Contact:86 137 5756 8585
Address:Poyang industry Park
Hangzhou Yanshan Chemical Co.,Ltd.
Contact:86-571- 87698076
Address:Room 1001, #1 Building, Zhongtian MCC, No.2 Youzhinong, Wenyi West Road, Xihu District, Hangzhou, China
Contact:+86-518-81061113
Address:No. 8 Lingzhou Road, Lianyungang, Jiangsu, China
JiangXi Hong Run Chemical Co., Ltd
Contact:+86-0791-88521351
Address:XingHuo industrial zone in YongXiu county
Doi:10.1055/s-1998-2076
(1998)Doi:10.1021/ic960555o
(1996)Doi:10.7164/antibiotics.49.944
(1996)Doi:10.1021/jo0705972
(2007)Doi:10.1016/0968-0896(96)00118-6
(1996)Doi:10.1016/0040-4020(82)87018-X
(1982)
